2022 Impact Factor
2.3

EDITORS IN CHIEF
M. B. Bilò (Italy)
P. Carreiro-Martins (Portugal)

DEPUTY EDITORS

R. Rodrigues Alves (Portugal)
D. Villalta (Italy)

ASSOCIATE EDITORS

R. Asero (Italy)
M. Branco Ferreira (Portugal)

L. Cecchi (Italy)
E. Scala (Italy)
D. Solé (Brasil)
G. Sturm (Austria)

EDITORIAL BOARD
I. Agache (Romania)
I. Annesi Maesano (France)
L. Antonicelli (Italy)
G. Azizi (Iran)
L.M. Borrego (Portugal)
K. Brockow (Germany)
S. Bavbek (Turkey)
E. Cichocka-Jarosz (Poland)
M. Cugno (Italy)
L. Delgado (Portugal)
P. Demoly (France)
G. D'Amato (Italy)
S. Durham (UK)
M. Faber (Belgium)
M. Fernandez-Rivas (Spain)
J. Fonseca (Portugal)
ZS. Gao (China)
G.P. Girolomoni (Italy)
E. Goudouris (Brasil)
A. Grumach (Brasil)
G. Kostantinou (Greece)
F. Levi-Shaffer (Israel)
M. Maurer (Germany)
L. Mayorga (Spain)
C. Micheletto (Italy)
M. Morais de Almeida (Portugal)
G. Moscato (Italy)
A. Musarra (Italy)
C. Nunes (Portugal)
M. Ollert (Lussemburgo)
P. Parronchi (Italy)
G. Passalacqua (Italy)
E. Pedro (Portugal)
A. Perino (Italy)
O. Quercia (Italy)
A. Romano (Italy)
G. Scadding (UK)
A. Todo Bom (Portugal)
A. Tedeschi (Italy)
R. van Ree (Netherland)
S. Voltolini (Italy)

FOUNDERS

F. Bonifazi (Italy)
A. Sabbah (France)

*************************

Chief Executive Officer
Ludovico Baldessin

Editorial Coordinator
Barbara Moret

Publishing Editor
Jessica Guenzi
j.guenzi@lswr.it

Sales

dircom@lswr.it

EDRA SpA
Via G. Spadolini, 7

20141 Milano - Italy
Ph. 0039 (0)2-88184.1
Fax 0039 (0)2-88184.301
www.edraspa.it

Follow us on LinkedIn

Table of Contents »

Angiotensin Converting Enzyme-2 (ACE2) Receptors, asthma and severe COVID-19 infection risk

A. B. Öztürk aysebilgeozturk@yahoo.com¹, B. Çaðlayan²

Show more: Author information and Publication history

Doi
http://doi.org/10.23822/EurAnnACI.1764-1489.169

Key words
Asthma; severe asthma; infection; COVID-19; ACE2; TMPRSS2; SARS-CoV-2.

Cite article as:
AB Öztürk, B Çaðlayan, Angiotensin Converting Enzyme-2 (ACE2) Receptors, asthma and severe COVID-19 infection risk, Eur Ann Allergy Clin Immunol 2020;52(6):282-285. doi:10.23822/EurAnnACI.1764-1489.169.

FULL TEXT